ABBV

Want Decades of Passive Income? Buy This Index Fund and Hold It Forever.

12/14 06:15 am

Women’s Healthcare Market Worth USD 46.76 Billion by 2033 Driven by Rising Demand for Reproductive, Preventive, and Digital Health Solutions – SNS Insider

12/13 09:10 pm

Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026

12/12 01:23 pm

Dividend Powerhouses: 3 Blue-Chip Stocks Built for the Long Haul

12/12 12:10 pm

Is AbbVie Stock Too Cheap to Ignore at Today's Price?

12/11 12:06 pm

DISCO Pharmaceuticals Appoints Mark Manfredi as CEO and Announces Final Close of €36 Million Seed Financing

12/11 06:00 am

Genmab Announces New Data from Phase 1b/2 EPCORE® CLL-1 Highlighting Potential of Epcoritamab as Monotherapy and in Combination for Patients with Richter Transformation (RT)

12/08 05:30 pm

OSE Immunotherapeutics annonce un amendement stratégique au partenariat avec AbbVie sur le développement d’ABBV-230

12/08 02:30 am

OSE Immunotherapeutics Announces Strategic Amendment to AbbVie’s Partnership on ABBV-230 Development

12/08 02:30 am

Ophthalmic Drugs Market Size to Cross USD 62.74 Billion by 2032, Driven by Advances in Eye Care Treatments and Rising Global Vision Disorders - SNS Insider

12/07 09:05 am

Genmab Presents Pivotal Phase 3 Data from EPCORE® FL-1 Trial Demonstrating Clinical Benefit of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide (R2) in Patients with Relapsed or Refractory Follicular Lymphoma

12/07 08:50 am

Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)

12/06 10:30 am

3 Top ETFs I Plan to Pile Into in December to Boost My Passive Income in 2026

12/04 07:15 am

ADARx Pharmaceuticals Appoints Mary Tagliaferri, M.D., to its Board of Directors

12/02 10:00 am

AbbVie Scores Canadian Reimbursement Recommendations For Blockbuster Ulcerative Colitis Drug Skyrizi

11/28 11:50 am

Atopic Dermatitis Drugs Market to Reach $29.43 Billion by 2032, Driven by Rising Disease Prevalence & Strong Therapeutic Innovation | SNS Insider

11/28 01:28 am

5 Dividend Stocks to Hold for the Next 10 Years

11/24 08:25 am

Why Johnson & Johnson's Share Price Is Popping This Month

11/19 01:24 pm

Healthcare Rotation Underway: 3 Stocks Leading the Charge

11/19 10:37 am

AbbVie Stock Falls 4% -- What Investors Need to Know

11/17 08:17 am

This Sector Is Suddenly Crushing the Broader Market. Should You Invest $1,000?

11/17 06:25 am

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.

11/15 08:25 am

Is the Schwab U.S. Dividend Equity ETF the "Ultimate Retirement Fund" for Investors?

11/13 05:08 am

NEXGEL (NXGL) Q3 2025 Earnings Call Transcript

11/11 06:05 pm

What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill.

11/09 12:05 pm

Got $5,000? These Are 3 of the Cheapest Growth Stocks to Buy Right Now

11/09 05:21 am

Is the Schwab U.S. Dividend Equity ETF a Buy Now?

11/08 09:31 am

ADARx Pharmaceuticals Announces Positive Interim Phase 1 Clinical Data for its Novel siRNA Targeting Complement Factor B (CFB)

11/07 12:00 pm

High Concentration mAb Products Market Advancing Precision Biopharmaceutical Therapeutics – Towards Healthcare

11/06 12:00 pm

Choroidal Neovascularization Market to Witness Accelerated Growth Throughout the Forecast Period (2025–2034) Due to Advancement in Anti-VEGF Therapies | DelveInsight

11/05 02:00 pm

Schwab U.S. Dividend Equity ETF (SCHD) Offers Higher Yield and Lower Fees Than ProShares S&P 500 Dividend Aristocrats ETF (NOBL)

11/04 12:01 pm

2 Healthcare Stocks for Individual Investors With a 10-Year Time Horizon

11/04 06:15 am

My Favorite Dividend King to Buy in November

11/03 08:30 am

2 Magnificent Dividend Stocks to Buy and Hold Forever

11/02 10:15 am

2 Top ETFs I Can't Wait to Buy More of in My Retirement Account This November

11/02 09:14 am

Why AbbVie Stock Flopped on Friday

11/01 06:15 am

AbbVie Raises 2025 Outlook Helped By Strong Immunology Growth, Boost Dividend

10/31 11:47 am

Anti-Inflammatory Drugs Market to Reach USD 274.79 Billion by 2034, Fueled by Rising Innovation and Accessibility

10/31 11:00 am

Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter and First Nine Months of 2025

10/31 02:35 am

Want Decades of Passive Income? Buy This Index Fund and Hold It Forever.

10/28 08:27 am

Billionaire Israel "Izzy" Englander Has Loaded Up on This Dividend King. Should You?

10/28 06:26 am

Prediction: These Dividend Stocks Could Outperform Growth Stocks in the Next Decade

10/26 11:21 am

AbbVie Draws Growing Institutional Confidence As Investors Seek Steady Growth

10/23 01:07 pm

Bullish Bet: Investment Manager Makes Strategic Buy of Prologis Stock

10/23 10:33 am

United States Breast Reconstruction Market Growth Trends and Forecast Report 2025-2033, Profiles of Mentor Worldwide, AbbVie, Integra, Sientra, Stryker, Establishment Labs, RTI Surgical, TELA Bio

10/23 04:52 am

Abacus FCF Advisors Bets $16 Million on Hilton Even as Hotel Stock Lags Market

10/21 03:12 pm

Global Liquid Filters Market to Reach US$ 26.5 Billion by 2033 | Astute Analytica

10/20 12:30 pm

3 Dividend-Paying ETFs to Double Down On Even if the S&P 500 Sells Off in October

10/20 08:21 am

OSE Immunotherapeutics Reports First Half 2025 Financial Results

10/15 01:00 pm

OSE Immunotherapeutics publie ses résultats financiers du 1er semestre 2025

10/15 01:00 pm